Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazepam 1% Oral Gel in Burning Mouth Syndrome
NCT05872789Completed
- Sponsor
- University of Catania
- Start
- May 2020
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in burning mouth syndrome (BMS) comparing Diazepam 1% Oral gel with Placebo (2 arms). Primary endpoint: Evolution of burning mouth at 2 months. Started May 2020; status: completed.
02
Drugs
diazepam nasal spray
03
Conditions
burning mouth syndrome (BMS)
Beyond the preview
Go deeper on NCT05872789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05872789.